Listed

Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 20, 2019 and accepted by EDGAR at May 20, 2019, 14:35 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-01-01 to 2019-03-31$5.3kus-gaap:Revenues
Cost of revenue3 months2019-01-01 to 2019-03-31$8.2kus-gaap:CostOfRevenue
Gross profit3 months2019-01-01 to 2019-03-31−$2.9kus-gaap:GrossProfit
Operating income3 months2019-01-01 to 2019-03-31−$367.1kus-gaap:OperatingIncomeLoss
Interest expense3 months2019-01-01 to 2019-03-31$133.3kus-gaap:InterestExpense
Net income3 months2019-01-01 to 2019-03-31−$559.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2019-01-01 to 2019-03-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2019-01-01 to 2019-03-31−$101.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-03-31$7.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$44.4kus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$2.4mus-gaap:Assets
Total liabilitiesAt period end2019-03-31$1.2mus-gaap:Liabilities
Shareholders' equityAt period end2019-03-31$1.2mus-gaap:StockholdersEquity
Shares outstandingAt period end2019-03-31387,553,890 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001607062-19-000235. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.